Next Article in Journal
Some Characteristics of Free Cell Population in the Airways of Rats after Intratracheal Instillation of Copper-Containing Nano-Scale Particles
Next Article in Special Issue
Potential Application of Curcumin and Its Analogues in the Treatment Strategy of Patients with Primary Epithelial Ovarian Cancer
Previous Article in Journal
Hepatoma-Derived Growth Factor Upregulation Is Correlated with Prognostic Factors of Early-Stage Cervical Adenocarcinoma
Open AccessReview

Therapeutic Phytogenic Compounds for Obesity and Diabetes

by 1,†, 1,† and 1,2,*
1
Department of Brain Science, Daegu Gyeongbuk Institute of Science & Technology, 333, Techno Jungang-daero, Hyeonpung-myeon, Dalseong-gun, Daegu 711-873, Korea
2
Neurometabolomics Research Center, Daegu Gyeongbuk Institute of Science & Technology, 333, Techno Jungang-daero, Hyeonpung-myeon, Dalseong-gun, Daegu 711-873, Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2014, 15(11), 21505-21537; https://doi.org/10.3390/ijms151121505
Received: 24 October 2014 / Revised: 12 November 2014 / Accepted: 14 November 2014 / Published: 21 November 2014
(This article belongs to the Special Issue Bioactive Phytochemicals in Functional Foods for Cancer Prevention)
Natural compounds have been used to develop drugs for many decades. Vast diversities and minimum side effects make natural compounds a good source for drug development. However, the composition and concentrations of natural compounds can vary. Despite this inconsistency, half of the Food and Drug Administration (FDA)-approved pharmaceuticals are natural compounds or their derivatives. Therefore, it is essential to continuously investigate natural compounds as sources of new pharmaceuticals. This review provides comprehensive information and analysis on natural compounds from plants (phytogenic compounds) that may serve as anti-obesity and/or anti-diabetes therapeutics. Our growing understanding and further exploration of the mechanisms of action of the phytogenic compounds may afford opportunities for development of therapeutic interventions in metabolic diseases. View Full-Text
Keywords: phytogenic compounds; obesity; diabetes phytogenic compounds; obesity; diabetes
Show Figures

Graphical abstract

MDPI and ACS Style

Jung, H.S.; Lim, Y.; Kim, E.-K. Therapeutic Phytogenic Compounds for Obesity and Diabetes. Int. J. Mol. Sci. 2014, 15, 21505-21537.

AMA Style

Jung HS, Lim Y, Kim E-K. Therapeutic Phytogenic Compounds for Obesity and Diabetes. International Journal of Molecular Sciences. 2014; 15(11):21505-21537.

Chicago/Turabian Style

Jung, Hee S.; Lim, Yun; Kim, Eun-Kyoung. 2014. "Therapeutic Phytogenic Compounds for Obesity and Diabetes" Int. J. Mol. Sci. 15, no. 11: 21505-21537.

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop